Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Lancet Neurol.

van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Soininen H, Tsolaki M, Verhey F, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Egret S, Palmqvist S, Hansson O, Visser PJ, Berkhof J, van der Flier WM, Alzheimer's Disease Neuroimaging Initiative.

doi: 10.1016/S1474-4422(19)30283-2.

Aging and Cognitive FunctionsAlzheimer’s Disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

JAMA Neurol.

Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.1001/jamaneurol.

Aging and Cognitive Functions

Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study

J Alzheimers Dis.

Lizio R, Babiloni C, Percio CD, Losurdo A, Vernò L, Tommaso M, Montemurno A, Dalfino G, Cirillo P, Soricelli A, Ferri R, Noce G, Pascarelli MT, Catania V, Nobili F, Famá F, Orzi F, Giubilei F, Buttinelli C, Triggiani AI, Frisoni GB, Scisci AM, Mastrofilippo N, Procaccini DA, Gesualdo L

doi: 10.3233/JAD-180245.

Aging and Cognitive FunctionsAlzheimer’s Disease

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

JAMA Neurol.

Wolk AD, Sadowsky C, Safirstein B, Rinne JO, Duara J, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F

doi: 10.1001/

Aging and Cognitive FunctionsAnxiety and DepressionDementia

Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment

J Alzheimers Dis.

Moon B, Kim S, Park YH, Lim JS, Youn YC, Kim SY, Jang JW, Alzheimer’s Disease Neuroimaging Initiative

doi: 10.3233/JAD-170225.

Aging and Cognitive FunctionsDementia

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information

J Alzheimers Dis.

Steenland K, Zhao L, John SE, Goldstein FC, Levey A, Alvaro A; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.3233/JAD-170769.

Dementia

Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

Neuroimage Clin.

Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L; Alzheimer's Disease Neuroimaging Initiative

doi: 10.1016/j.nicl.2018.101637.

Alzheimer’s Disease

Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests

J Neurol.

De Simone MS, Perri R, Fadda L, Caltagirone C, Carlesimo GA

doi: 10.1007/s00415-018-9108-0.

Aging and Cognitive FunctionsDementia

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia

J Neurol Neurosurg Psychiatry.

Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A

doi: 10.1136/jnnp-2015-311486.

Related content

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information

Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia